Analyzing Navidea Biopharmaceuticals (NYSE:NAVB) & Heska (NASDAQ:HSKA)
Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) and Heska (NASDAQ:HSKA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Institutional and Insider Ownership 5.6% of Navidea Biopharmaceuticals shares are […]
Source: etfdailynews.com